• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析弥漫性大 B 细胞淋巴瘤的批量转录组。

Dissecting bulk transcriptomes of diffuse large B cell lymphoma.

机构信息

Caryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA.

Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA.

出版信息

Cancer Cell. 2021 Oct 11;39(10):1305-1307. doi: 10.1016/j.ccell.2021.09.006. Epub 2021 Sep 30.

DOI:10.1016/j.ccell.2021.09.006
PMID:34597590
Abstract

Diffuse large B cell lymphoma (DLBCL) is a markedly phenotypically heterogenous disease, frequently assessed using bulk genomic techniques that blur the intrinsic heterogeneity of each tumor. In this issue of Cancer Cell, Steen et al. have utilized a computational framework called EcoTyper to skillfully dissect bulk transcriptomic tumor profiles into different cell type components in an unsupervised manner.

摘要

弥漫性大 B 细胞淋巴瘤 (DLBCL) 是一种显著表型异质性疾病,常使用批量基因组技术进行评估,从而模糊了每个肿瘤的固有异质性。在本期《癌细胞》中,Steen 等人利用一种称为 EcoTyper 的计算框架,以非监督的方式巧妙地将批量转录组肿瘤图谱解析为不同的细胞类型成分。

相似文献

1
Dissecting bulk transcriptomes of diffuse large B cell lymphoma.解析弥漫性大 B 细胞淋巴瘤的批量转录组。
Cancer Cell. 2021 Oct 11;39(10):1305-1307. doi: 10.1016/j.ccell.2021.09.006. Epub 2021 Sep 30.
2
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.弥漫性大 B 细胞淋巴瘤中肿瘤细胞状态和生态系统的景观。
Cancer Cell. 2021 Oct 11;39(10):1422-1437.e10. doi: 10.1016/j.ccell.2021.08.011. Epub 2021 Sep 30.
3
Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles.利用分子谱综合分析细化弥漫性大 B 细胞淋巴瘤亚群。
EBioMedicine. 2019 Oct;48:58-69. doi: 10.1016/j.ebiom.2019.09.034. Epub 2019 Oct 21.
4
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces.弥漫性大 B 细胞淋巴瘤的肿瘤内异质性涉及诱导多样化的基质-肿瘤界面。
EBioMedicine. 2020 Nov;61:103055. doi: 10.1016/j.ebiom.2020.103055. Epub 2020 Oct 20.
5
Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.通过详细的 SNP 芯片分析对弥漫性大 B 细胞淋巴瘤的基因组失衡进行特征描述。
Int J Cancer. 2015 Mar 1;136(5):1033-42. doi: 10.1002/ijc.29072. Epub 2014 Jul 22.
6
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.全面的miRNA序列分析揭示了弥漫性大B细胞淋巴瘤患者的生存差异。
Genome Biol. 2015 Jan 29;16(1):18. doi: 10.1186/s13059-014-0568-y.
7
Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).原发性鼻窦弥漫性大B细胞淋巴瘤(DLBCL)的临床病理特征和基因组图谱显示1q31区域获得以及编码RGS1蛋白;RGS1免疫组化高表达与未另行指定(NOS)的DLBCL患者总生存期较差相关。
Histopathology. 2017 Mar;70(4):595-621. doi: 10.1111/his.13106. Epub 2017 Jan 9.
8
Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.鉴定 PLA2G7 为弥漫性大 B 细胞淋巴瘤的一种新型生物标志物。
BMC Cancer. 2021 Aug 17;21(1):927. doi: 10.1186/s12885-021-08660-4.
9
Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center.原发性骨淋巴瘤预后良好,具有独特的基因表达特征,类似于生发中心起源的弥漫性大B细胞淋巴瘤。
Am J Surg Pathol. 2017 Oct;41(10):1309-1321. doi: 10.1097/PAS.0000000000000923.
10
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.PRDM1/BLIMP-1功能丧失导致活化B细胞样弥漫性大B细胞淋巴瘤预后不良。
Leukemia. 2017 Mar;31(3):625-636. doi: 10.1038/leu.2016.243. Epub 2016 Aug 29.

引用本文的文献

1
Single-cell profiling-guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphoma.单细胞分析指导下的 c-Fos 和组蛋白去乙酰化酶抑制剂联合治疗弥漫性大 B 细胞淋巴瘤。
Clin Transl Med. 2022 May;12(5):e798. doi: 10.1002/ctm2.798.